Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Percutaneous Deployment of the Sinus-SuperFlex-DS Stent for Hybrid Stage I Palliation in Neonates Weighing ≤ 2.5 kg: A Multicenter Study.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

Same author

Pulmonary artery banding in dilated cardiomyopathy: impact of age.

Cardiology in the young·2025

Same author

Interventional Strategies for Full Hybrid/Norwood, the Double Intention, Double Intervention (DIDI) Approach.

Seminars in thoracic and cardiovascular surgery·2025

Same author

Aspirin in Children; are There Not Two Sides of the Same Coin?

Pediatric cardiology·2024

Same author

Perioperative anesthetic management of patients with hypoplastic left heart syndrome undergoing the comprehensive stage II surgery-A review of 148 cases.

Paediatric anaesthesia·2024

Same author

A Global Perspective on PDA Management in the Extremely Premature: Shifting Trend Toward Transcatheter Closure.

Journal of the Society for Cardiovascular Angiography & Interventions·2024

Search research articles

Related Experiment Video

Updated: May 7, 2025

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Proposal: Bold New Indications for Transcatheter Pulmonary Flow Restrictors.

Dietmar Schranz¹

¹Pediatric Heart Center, Johann-Wolfgang-Goethe University Clinic, Theodor-Storm-Kai 7, 60596, Frankfurt, Germany. dietmar.schranz@ukffm.de.

Pediatric Cardiology

|January 5, 2025

Summary

Pulmonary flow restrictors (PFRs) show promise for managing congenital heart defects like hypoplastic left heart syndrome (HLHS) and dilated cardiomyopathy (DCM) in newborns. Tailored PFRs may reduce mortality and improve quality of life, potentially avoiding complex surgeries.

Keywords:

Borderline LV DCM Dilated cardiomyopathy HLHS Hypoplastic left heart syndrome MVP PFR Pulmonary flow restrictor Treatment

More Related Videos

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

Related Experiment Videos

Last Updated: May 7, 2025

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model

Published on: November 24, 2014

Area of Science:

Pediatric Cardiology
Biomedical Engineering
Neonatal Intensive Care

Background:

Hypoplastic left heart syndrome (HLHS) and dilated cardiomyopathy (DCM) present significant challenges in neonates.
Current management often involves invasive procedures, carrying substantial risks for vulnerable infants.

Purpose of the Study:

To present a proof of concept for using pulmonary flow restrictors (PFRs) in managing complex neonatal heart conditions.
To explore the potential of PFRs in improving outcomes for neonates with HLHS and infants with DCM.

Main Methods:

Utilizing clinical experience with MVP™-devices for pulmonary flow restriction.
Exploring manually adjustable PFRs tailored to individual patient size and hemodynamic needs.

Main Results:

PFRs offer a potential non-surgical approach to improve outcomes in HLHS and DCM.
Tailored PFRs can reduce mortality and enhance quality of life, potentially avoiding general anesthesia and major surgery.

Conclusions:

Pulmonary flow restrictors represent a promising advancement in the care of neonates with congenital heart disease and DCM.
Addressing the limited availability of appropriately sized devices is key to broader adoption and benefiting infants worldwide.